Literature DB >> 18256209

Independent loss of immunogenic proteins in Mycobacterium ulcerans suggests immune evasion.

Charlotte A Huber1, Marie-Thérèse Ruf, Gerd Pluschke, Michael Käser.   

Abstract

The highly immunogenic mycobacterial proteins ESAT-6, CFP-10, and HspX represent potential target antigens for the development of subunit vaccines and immunodiagnostic tests. Recently, the complete genome sequence revealed the absence of these coding sequences in Mycobacterium ulcerans, the causative agent of the emerging human disease Buruli ulcer. Genome reduction and the acquisition of a cytopathic and immunosuppressive macrolide toxin plasmid are regarded as crucial for the emergence of this pathogen from its environmental progenitor, Mycobacterium marinum. Earlier, we have shown the evolution of M. ulcerans into two distinct lineages. Here, we show that while the genome of M. marinum M contains two copies of the esxB-esxA gene cluster at different loci (designated MURD4 and MURD152), both copies are deleted from the genome of M. ulcerans strains belonging to the classical lineage. Members of the ancestral lineage instead retained some but disrupted most functional MURD4 or MURD152 copies, either by newly identified genomic insertion-deletion events or by conversions of functional genes to pseudogenes via point mutations. Thus, the esxA (ESAT-6), esxB (CFP-10), and hspX genes are located in hot-spot regions for genomic variation where functional disruption seems to be favored by selection pressure. Our detailed genomic analyses have identified a variety of independent genomic changes that have led to the loss of expression of functional ESAT-6, CFP-10, and HspX proteins. Loss of these immunodominant proteins helps the bacteria bypass the host's immunological response and may represent part of an ongoing adaptation of M. ulcerans to survival in host environments that are screened by immunological defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256209      PMCID: PMC2292651          DOI: 10.1128/CVI.00472-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  49 in total

1.  ACT: the Artemis Comparison Tool.

Authors:  Tim J Carver; Kim M Rutherford; Matthew Berriman; Marie-Adele Rajandream; Barclay G Barrell; Julian Parkhill
Journal:  Bioinformatics       Date:  2005-06-23       Impact factor: 6.937

2.  Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans.

Authors:  Timothy P Stinear; Hui Hong; Wafa Frigui; Melinda J Pryor; Roland Brosch; Thierry Garnier; Peter F Leadlay; Stewart T Cole
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.

Authors:  Sarojini Adusumilli; Armand Mve-Obiang; Tim Sparer; Wayne Meyers; John Hayman; Pamela Long Claus Small
Journal:  Cell Microbiol       Date:  2005-09       Impact factor: 3.715

4.  A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.

Authors:  Armand Mve-Obiang; Richard E Lee; Edward S Umstot; Kristin A Trott; Timothy C Grammer; John M Parker; Brian S Ranger; Robert Grainger; Engu A Mahrous; P L C Small
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  PCR amplification with primers based on IS2404 and GC-rich repeated sequence reveals polymorphism in Mycobacterium ulcerans.

Authors:  Anthony Ablordey; Roman Kotlowski; Jean Swings; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans.

Authors:  Timothy P Stinear; Melinda J Pryor; Jessica L Porter; Stewart T Cole
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

7.  The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.

Authors:  Y Yuan; D D Crane; R M Simpson; Y Q Zhu; M J Hickey; D R Sherman; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

10.  Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control.

Authors:  Paul D R Johnson; Timothy Stinear; Pamela L C Small; Gerd Pluschke; Richard W Merritt; Francoise Portaels; Kris Huygen; John A Hayman; Kingsley Asiedu
Journal:  PLoS Med       Date:  2005-04-26       Impact factor: 11.069

View more
  14 in total

1.  Large sequence polymorphisms unveil the phylogenetic relationship of environmental and pathogenic mycobacteria related to Mycobacterium ulcerans.

Authors:  Michael Käser; Julia Hauser; Pamela Small; Gerd Pluschke
Journal:  Appl Environ Microbiol       Date:  2009-07-10       Impact factor: 4.792

Review 2.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

3.  Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors.

Authors:  Joan Joseph; Raquel Fernández-Lloris; Elías Pezzat; Narcís Saubi; Pere-Joan Cardona; Beatriz Mothe; Josep Maria Gatell
Journal:  J Biomed Biotechnol       Date:  2010-06-27

4.  Lack of insertional-deletional polymorphism in a collection of Mycobacterium ulcerans isolates from Ghanaian Buruli ulcer patients.

Authors:  Michael Käser; Oliver Gutmann; Julia Hauser; Tim Stinear; Stewart Cole; Dorothy Yeboah-Manu; Gregor Dernick; Ulrich Certa; Gerd Pluschke
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

5.  Single nucleotide polymorphisms on the road to strain differentiation in Mycobacterium ulcerans.

Authors:  Michael Käser; Julia Hauser; Gerd Pluschke
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

6.  On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.

Authors:  Kenneth D Doig; Kathryn E Holt; Janet A M Fyfe; Caroline J Lavender; Miriam Eddyani; Françoise Portaels; Dorothy Yeboah-Manu; Gerd Pluschke; Torsten Seemann; Timothy P Stinear
Journal:  BMC Genomics       Date:  2012-06-19       Impact factor: 3.969

7.  Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana.

Authors:  Katharina Röltgen; Weihong Qi; Marie-Thérèse Ruf; Ernestina Mensah-Quainoo; Sacha J Pidot; Torsten Seemann; Timothy P Stinear; Michael Käser; Dorothy Yeboah-Manu; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2010-07-20

Review 8.  Computational resources in infectious disease: limitations and challenges.

Authors:  Eva C Berglund; Björn Nystedt; Siv G E Andersson
Journal:  PLoS Comput Biol       Date:  2009-10-26       Impact factor: 4.475

9.  Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing.

Authors:  Weihong Qi; Michael Käser; Katharina Röltgen; Dorothy Yeboah-Manu; Gerd Pluschke
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

10.  Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates.

Authors:  Azeem Mehmood Butt; Izza Nasrullah; Shifa Tahir; Yigang Tong
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.